Modern approaches to diagnosing and preventing malignization of peptic ulcer in the practice of the general practitioner from the perspective of evidence-based medicine.
DOI:
https://doi.org/10.58676/sjmas.v2i6.76Keywords:
Peptic ulcer disease (PUD), Gastric cancer (GC), Helicobacter pylori (H. pylori), Malignization prevention, , Diagnostic methodsAbstract
Abstract
Background: Peptic ulcer disease (PUD) is a prevalent gastrointestinal disorder that affects millions globally and has the potential to transform into gastric cancer (GC). GC ranks as the fifth most common cancer and is notably lethal. A significant correlation exists between PUD and Helicobacter pylori infection, which disrupts the stomach lining, leading to ulcers that may become malignant if not properly managed.
Methods and Materials: This study employed a systematic analysis and meta-analysis approach, gathering data from multiple medical databases including Medscape, Medline, Scopus, Pubmed, and various gastrointestinal guidelines from regions such as Malaysia, Europe, and the United States. The primary methods involved comparing the risk of malignization between gastric and duodenal ulcers, assessing the sensitivity of different diagnostic methods, and determining optimal prevention strategies.
Results: The findings indicate that gastric ulcers have a higher risk of malignization compared to duodenal ulcers. Diagnostic methods such as endoscopic biopsy demonstrated higher sensitivity for early malignization detection. Screening programs, especially those targeting H. pylori eradication, significantly reduce the incidence and mortality rates associated with gastric cancer.
Conclusion: Early diagnosis and prevention of PUD malignization are vital for improving patient outcomes. Effective strategies include the use of sensitive diagnostic methods and comprehensive screening programs for H. pylori. Lifestyle modifications and vigilant monitoring by healthcare professionals are also crucial in reducing the risk of peptic ulcer malignization and subsequent gastric cancer development.
References
Ren, J., Jin, X., Li, J., Li, R., Gao, Y. Zhang, J., Wang, X., & Wang, G. (2022). The global burden of peptic ulcer disease in 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. International Journal of Epidemiology 51(5): 1666–1676,
Rawla, P., & Barsouk, A. (2019). Epidemiology of gastric cancer: global trends, risk factors, and prevention. Przeglad Gastroenterologiczny 14(1): 26–38.
Xie, X., Ren, K., Zhou, Z. et al. The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study. BMC Gastroenterol 22, 58 (2022).
Grant. GLOBOCAN 2022: The latest global cancer data shows rising incidence and stark inequities. UICC - 2024.
Rawla, P., & Barsouk, A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Przeglad gastroenterologiczny - 2019 - 14(1), 26–38
Cancer in Russia - 2023, December 21 - Statista.
Dottie. Stomach cancer - PORTAL MYHEALTH. PORTAL MyHEALTH. - 2017, March 7
White, J. R., & Banks, M. (2022). Identifying the pre-malignant stomach: from guidelines to practice. Translational Gastroenterology and Hepatology 7: 8.
Hong, J., Zuo, W., Wang, A., Xu, S., Tu, L., Chen, Y., ...& Lu, N. (2014). Gastric ulcer patients are more susceptible to developing gastric cancer compared with concomitant gastric and duodenal ulcer patients. Oncology Letters 8: 2790-2794.
Lord, R., El-Feki, M., Tomos, L., Mohammed, N, Subramanian, V. & Rembacken B.J. (2018). Giant gastric ulcers: Malignancy yield and predictors from a 10-year retrospective single centre cohort. United European Gastroenterology Journal 6(7):1000-1006.
Chen, Z. D., Zhang, P. F., Xi, H. Q., Wei, B., Chen, L., & Tang, Y. (2021). Recent advances in the diagnosis, staging, treatment, and prognosis of advanced gastric cancer: A literature review. Frontiers in medicine 8: 744839.
Lee, S. W., Chang, C. S., Yeh, H. J., Lien, H. C., Lee, T. Y., & Peng, Y. C. (2017). The Diagnostic value of alarm features for identifying types and stages of upper gastrointestinal malignancies. Gastroenterology Research 10(2), 120–125.
Wang, Z., Mo, T.M., Tian, L., & Chen, J.Q. (2021). Gastrin-17 combined with CEA, CA12-5, and CA19-9 improves the sensitivity for the diagnosis of gastric cancer. Int J Gen Med. 12(14) :8087-8095. PMID: 34795515; PMCID: PMC8594785.
He, C.Z., Zhang, K.H., Li, Q., Liu, X.H., Hong, Y., & Lv, N.H. (2013). Combined use of AFP, CEA, CA125, and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol. 14(13): 87. PMID: 23672279; PMCID: PMC3655895.
Xia, J.Y., & Aadam, A.A. (2022). Advances in screening and detection of gastric cancer. Journal of Surgical Oncology 125(7): 1104-1109.
Hu, B., El Hajj, N., Sittler, S., Lammert, N., Barnes, R., & Meloni-Ehrig, A. (2012). Gastric cancer: Classification, histology, and application of molecular pathology. Journal Of Gastrointestinal Oncology 3(3): 251-261.
Meining, A., & Rösch, T. Endoscopy campus.
El Abiad, R., & Gerke, H. (2012). Gastric cancer: endoscopic diagnosis and staging. Surgical oncology clinics of North America 21( 1): 1-19.
Goel, A., Sharma, R., Khan, M., et al. Malignant vs benign gastric ulcer (barium). Reference article, Radiopaedia.org (Accessed on February 21, 2024)
Health Commission Of The People's Republic Of China N. (2022). National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version). Chinese Journal of Cancer Research = Chung-kuo yen cheng yen chiu, 34(3), 207–237.
Hallinan, J. T., & Venkatesh, S. K. (2013). Gastric carcinoma: Imaging diagnosis, staging and assessment of treatment response. Cancer imaging: the official publication of the International Cancer Imaging Society 13(2), 212–227.
Conti, C. B., Agnesi, S., Scaravaglio, M., Masseria, P., Dinelli, M. E., Oldani, M., & Uggeri, F. (2023). Early gastric cancer: Update on prevention, diagnosis, and treatment. International journal of environmental research and public health 20(3): 2149.
Jun, J. K., Choi, K. S., Lee, H. Y., Suh, M., Park, B., Song, S. H., Jung, K. W., Lee, C. W., Choi, I. J., Park, S., & Lee, D. (2017). Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology152(6):1319-1328.e7.
Cárdenas-Mondragón, M. G., Torres, J., Flores-Luna, L., Carreón-Talavera, R., Camorlinga-Ponce, M., & Fuentes-Pananá, E. M. (2015). Epstein-Barr virus association with peptic ulcer disease. Analytical cellular pathology (Amsterdam): 164840.
Sitarz, R., Skierucha, M., Mielko, J., Offerhaus, G.J.A, Maciejewski, R., & Polkowski, W.P. (2018). Gastric cancer: epidemiology, prevention, classification, and treatment. CancerManag Res. 10: 239-248
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Han Shi An, Dr Ghassan Salibi, Prof Nikolaos Tzenios
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
